India's pharmaceutical and API manufacturing industry continues to dominate global generic medicine production, accounting for 20% of worldwide exports by volume. Synthesis facilities operating across Hyderabad's Genome Valley, Mumbai's MIDC corridors, Ahmedabad's pharma clusters, and Visakhapatnam's PCPIR zones are intensifying their organic synthesis pipelines to meet surging domestic and export demand and the quality of aryl halide intermediates sourced directly determines batch integrity and regulatory compliance. 

Formulation chemists, API synthesis heads, medicinal chemists, and pharmaceutical procurement officers who operate within India's regulated drug manufacturing ecosystem rely on SARA Research & Development Centre (SRDC) — widely respected biphenyl suppliers in India for pharmaceutical-grade 2-bromobiphenyl (CAS No. 2052-07-5). Governed precisely by the 2-bromobiphenyl formula (C₁₂H₉Br, MW 233.1), this compound serves as a critical building block for complex molecular architectures, advanced cross-coupling reactions, and multi-step API synthesis programmes. From small-scale R&D batches to large commercial consignments, every delivery meets the stringent purity standards demanded by regulatory-compliant manufacturing environments. 

SARA Research & Development Centre (SRDC) specialises in this critical intersection of innovation and efficiency, delivering custom synthesis, process R&D, and material science specialty chemicals solutions from its Navi Mumbai headquarters  a trusted partner across pharmaceuticals, nutraceuticals, and agrochemicals for over three decades. 

Accelerate your API pipeline. Enquire now for COA, MSDS & confirmed pricing. 

Visit our page:  https://sararesearch.com/product-details/2-bromo-biphenyl 

Address: W‐250, M.I.D.C, TTC, Rabale, Navi Mumbai ‐ 400 701, Maharashtra, India 

Contact us: https://sararesearch.com/contact-us 

Visit our website:  https://sararesearch.com/